Related Experiment Video
Updated: Mar 20, 2026
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
15.2K
Monoclonal Antibodies for Lipid Management
Matthew J Feinstein1,2, Donald M Lloyd-Jones3,4
1Division of Cardiovascular Diseases, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Current Atherosclerosis Reports
|May 26, 2016
Summary
New PCSK9 inhibitors, delivered via injection, effectively lower LDL cholesterol, offering a promising new therapy for coronary heart disease risk reduction. Further long-term studies are needed to confirm sustained efficacy and safety.
Area of Science:
- Biochemistry
- Genetics
- Cardiology
Background:
- Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a key regulator of low-density lipoprotein cholesterol (LDL-c) levels.
- Elevated LDL-c is a major risk factor for coronary heart disease (CHD).
Purpose of the Study:
- To review the biology, genetics, and development of PCSK9 inhibitors.
- To summarize clinical trial data for monoclonal antibodies targeting PCSK9.
Main Methods:
- Review of biochemical and genetic studies.
- Analysis of data from phase III clinical trials of PCSK9 inhibitors.
Main Results:
- PCSK9 inhibitors demonstrate significant LDL-c lowering efficacy.
- Subcutaneously injected monoclonal antibodies targeting PCSK9 show acceptable safety in trials.
- These therapies may complement statin treatment in specific patient populations.
Conclusions:
- PCSK9 inhibitors represent a novel therapeutic class for managing LDL-c and reducing CHD risk.
- Longer-term data are essential to establish sustained efficacy and safety profiles.
More Related Videos
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.7K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
01:26Atherosclerosis III: Management
569
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
569
01:29Pharmacogenomics: Identification of New Drug Targets
75
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
75
01:24Lipid Absorption
3.3K
Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
3.3K
01:24Overview of Lipid Metabolism
6.5K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
6.5K
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
717
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
717